Picard Medical, Inc. (PMI)

Picard Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	0.1	0.24
Short-Term Investments	0.11	0.11
Cash & Cash Equivalents	0.21	0.36
Cash Growth	-41.57%	-
Receivables	0.51	0.63
Inventory	8.12	6.89
Other Current Assets	0.96	0.88
Total Current Assets	9.79	8.76
Property, Plant & Equipment	0.23	0.37
Goodwill and Intangibles	2.09	2.25
Total Long-Term Assets	2.32	2.61
Total Assets	12.11	11.37
Accounts Payable	5.29	3.08
Current Debt	20.41	4.37
Other Current Liabilities	9.62	1.76
Total Current Liabilities	35.33	9.21
Long-Term Debt	0.52	5.04
Other Long-Term Liabilities	0	0.67
Total Long-Term Liabilities	0.52	5.71
Total Liabilities	35.84	14.93
Total Debt	20.93	9.41
Debt Growth	122.37%	-
Retained Earnings	-49.84	-28.79
Comprehensive Income	0.28	0.29
Shareholders' Equity	-44	-23.82
Net Cash / Debt	-20.72	-9.06
Working Capital	-25.53	-0.45

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).